WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeStocks › SUPN

Which hedge funds own SUPN? SUPERNUS PHARMACEUTICALS, Q2 2026 13F holders

Healthcare · Open on the interactive board

7 of the hedge funds tracked by WhaleCreep disclosed a position in SUPN (SUPERNUS PHARMACEUTICALS) in their Q2 2026 13F filings, worth $382.4m in total. The largest holder by portfolio weight is Millennium Management at 0.1% of its book. 1 manager opened a new position this quarter: Tudor Investment. 2 exited: Farallon Capital Management, Point72 Asset Management LP.

7tracked managers holding
1opened this quarter
2exited this quarter

Which hedge funds hold SUPN? Current holders by portfolio weight

ManagerAs ofWeight of bookValueSharesΔ sharesAction
Millennium ManagementQ2 2026 0.1%$179.2m3,853,212 16% added
Woodline PartnersQ2 2026 0.1%$32.9m708,276 58% added
Renaissance Technologies LLCQ2 2026 0.1%$68.8m1,478,180 -13% reduced
Citadel AdvisorsQ2 2026 0.0%$63.9m1,373,982 -8% reduced
D. E. Shaw & CoQ2 2026 0.0%$35.7m767,668 23% added
Brevan Howard Capital ManagementQ2 2026 0.0%$694.3k14,929 28% added
Tudor InvestmentQ2 2026 0.0%$1.2m24,746 new

Exited since the previous quarter

ManagerPrior weightPrior value
Farallon Capital Management0.0%$206.8k
Point72 Asset Management LP1.5%$68.2m

How has hedge fund ownership of SUPN changed?

QuarterManagers holdingCombined value
Q2 20267$382.4m
Q1 20268$461.1m
Q4 20253$200.3m
Q3 20255$257.7m
Q2 20254$114.5m
Q1 20252$62.4m
Q4 20243$74.1m
Q3 20243$60.6m
Q2 20242$48.7m
Q1 20243$93.9m
Q4 20231$39.9m
Q3 20231$39.7m
Q2 20233$46.0m
Q1 20234$52.4m
Q4 20224$51.9m
Q3 20224$73.6m

Counts every tracked manager that disclosed SUPN in that quarter's filing, including managers that have since stopped filing.